These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 31069872)

  • 1. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review.
    Soleimani V; Delghandi PS; Moallem SA; Karimi G
    Phytother Res; 2019 Jun; 33(6):1627-1638. PubMed ID: 31069872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
    Albassam AA; Frye RF; Markowitz JS
    Chem Biol Interact; 2017 Jun; 271():24-29. PubMed ID: 28457856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Milk thistle in liver diseases: past, present, future.
    Abenavoli L; Capasso R; Milic N; Capasso F
    Phytother Res; 2010 Oct; 24(10):1423-32. PubMed ID: 20564545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-drug interactions of silymarin on the perspective of pharmacokinetics.
    Wu JW; Lin LC; Tsai TH
    J Ethnopharmacol; 2009 Jan; 121(2):185-93. PubMed ID: 19041708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The study of flavonolignan association patterns in fruits of diverging Silybum marianum (L.) Gaertn. chemotypes provides new insights into the silymarin biosynthetic pathway.
    Martinelli T; Whittaker A; Benedettelli S; Carboni A; Andrzejewska J
    Phytochemistry; 2017 Dec; 144():9-18. PubMed ID: 28863306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic potentials of milk thistle (Silybum marianum).
    Milić N; Milosević N; Suvajdzić L; Zarkov M; Abenavoli L
    Nat Prod Commun; 2013 Dec; 8(12):1801-10. PubMed ID: 24555302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models.
    Bijak M; Synowiec E; Sitarek P; Sliwiński T; Saluk-Bijak J
    Nutrients; 2017 Dec; 9(12):. PubMed ID: 29240674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract.
    Wen Z; Dumas TE; Schrieber SJ; Hawke RL; Fried MW; Smith PC
    Drug Metab Dispos; 2008 Jan; 36(1):65-72. PubMed ID: 17913795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the analysis of flavonolignans of Silybum marianum.
    Csupor D; Csorba A; Hohmann J
    J Pharm Biomed Anal; 2016 Oct; 130():301-317. PubMed ID: 27321822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity.
    Kawaguchi-Suzuki M; Frye RF; Zhu HJ; Brinda BJ; Chavin KD; Bernstein HJ; Markowitz JS
    Drug Metab Dispos; 2014 Oct; 42(10):1611-6. PubMed ID: 25028567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans.
    Chlopcíková S; Psotová J; Miketová P; Simánek V
    Phytother Res; 2004 Feb; 18(2):107-10. PubMed ID: 15022159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silybin and its congeners: from traditional medicine to molecular effects.
    Křen V; Valentová K
    Nat Prod Rep; 2022 Jun; 39(6):1264-1281. PubMed ID: 35510639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review.
    Tajmohammadi A; Razavi BM; Hosseinzadeh H
    Phytother Res; 2018 Oct; 32(10):1933-1949. PubMed ID: 30015401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism.
    Bijak M
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29125572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases.
    Abenavoli L; Izzo AA; Milić N; Cicala C; Santini A; Capasso R
    Phytother Res; 2018 Nov; 32(11):2202-2213. PubMed ID: 30080294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Milk thistle (
    Fanoudi S; Alavi MS; Karimi G; Hosseinzadeh H
    Drug Chem Toxicol; 2020 May; 43(3):240-254. PubMed ID: 30033764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study.
    Zhu HJ; Brinda BJ; Chavin KD; Bernstein HJ; Patrick KS; Markowitz JS
    Drug Metab Dispos; 2013 Sep; 41(9):1679-85. PubMed ID: 23835761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of silymarin in milk thistle seeds under drought stress.
    Keshavarz Afshar R; Chaichi MR; Ansari Jovini M; Jahanzad E; Hashemi M
    Planta; 2015 Sep; 242(3):539-43. PubMed ID: 25708739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical Standardization of Milk Thistle (
    Muchiri RN; van Breemen RB
    J Am Soc Mass Spectrom; 2024 Aug; 35(8):1726-1732. PubMed ID: 38953246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti- and pro-mutagenic effects of silymarin in the Ames bacterial reverse mutation assay.
    Kaleeswaran S; Sriram P; Prabhu D; ; ; Mathuram LN
    Phytother Res; 2009 Oct; 23(10):1378-84. PubMed ID: 19277970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.